These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 2238629)
1. The clinical use of oral sulfonylureas in the management of non-insulin dependent diabetes mellitus (NIDDM). Ponte CD W V Med J; 1990 Oct; 86(10):455-8. PubMed ID: 2238629 [TBL] [Abstract][Full Text] [Related]
2. The management of non-insulin-dependent diabetes mellitus in the elderly. Ruoff G J Fam Pract; 1993 Mar; 36(3):329-35. PubMed ID: 8454981 [TBL] [Abstract][Full Text] [Related]
3. Oral hypoglycemic agents in type II diabetes mellitus. Lubbos H; Miller JL; Rose LI Am Fam Physician; 1995 Nov; 52(7):2075-8. PubMed ID: 7484707 [TBL] [Abstract][Full Text] [Related]
4. Oral hypoglycemic agents in the treatment of type II diabetes. Tal A Am Fam Physician; 1993 Nov; 48(6):1089-95. PubMed ID: 8237731 [TBL] [Abstract][Full Text] [Related]
5. Antidiabetic agents. Francisco GE Prim Care; 1990 Sep; 17(3):499-519. PubMed ID: 2236334 [TBL] [Abstract][Full Text] [Related]
6. Practical considerations and guidelines for dosing sulfonylureas as monotherapy or combination therapy. Bell DS Clin Ther; 2004 Nov; 26(11):1714-27. PubMed ID: 15639686 [TBL] [Abstract][Full Text] [Related]
7. Exploring the role of sulfonylureas in the treatment of non-insulin-dependent diabetes mellitus. Graham JP; Stam D Pharm Pract Manag Q; 1997 Oct; 17(3):1-9. PubMed ID: 10173306 [TBL] [Abstract][Full Text] [Related]
9. The role of glimepiride in the effective management of Type 2 diabetes. Davis SN J Diabetes Complications; 2004; 18(6):367-76. PubMed ID: 15531188 [TBL] [Abstract][Full Text] [Related]
10. Efficacy of insulin and sulfonylurea combination therapy in type II diabetes. A meta-analysis of the randomized placebo-controlled trials. Johnson JL; Wolf SL; Kabadi UM Arch Intern Med; 1996 Feb; 156(3):259-64. PubMed ID: 8572835 [TBL] [Abstract][Full Text] [Related]
11. Insulin: either alone or combined with oral hypoglycemic agents. Firth RG Prim Care; 1988 Sep; 15(3):665-83. PubMed ID: 3054969 [TBL] [Abstract][Full Text] [Related]
14. Type II diabetes: role of first- and second-generation drugs. Washington SE; Mazzaferri EL Geriatrics; 1986 Nov; 41(11):51-6, 59-60, 64. PubMed ID: 3770483 [TBL] [Abstract][Full Text] [Related]
15. Beta cell response to oral glimepiride administration during and following a hyperglycaemic clamp in NIDDM patients. van der Wal PS; Draeger KE; van Iperen AM; Martini C; Aarsen M; Heine RJ Diabet Med; 1997 Jul; 14(7):556-63. PubMed ID: 9223393 [TBL] [Abstract][Full Text] [Related]
16. Oral sulfonylureas for the treatment of type II diabetes: an update. Shank WA; Morrison AD South Med J; 1986 Mar; 79(3):337-43. PubMed ID: 3082015 [TBL] [Abstract][Full Text] [Related]